One Zyme
One Zyme is developing an AI team-member for life sciences, leveraging AI to analyze scientific and market signals to help biopharma companies uncover opportunities swiftly. The company is early stage, with a focus on building its core product and scaling to enterprise clients through innovative AI-native SaaS solutions.
One Zyme is an AI-native company that builds autonomous AI agents to radically accelerate business development and competitive intelligence for biopharma organizations. Their platform helps BD and strategy teams surface partners, monitor competitors, and turn large volumes of scientific and commercial data into actionable insights. The team is composed of veterans from top big‑tech companies, venture capital firms, and major pharmaceutical labs.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for One Zyme.
One Zyme didn’t post a salary, so this is our estimate from similar listings.